カテゴリー： 世界, 医療/バイオ, LP Information

世界の鼻炎薬市場予測 2023年-2029年

【英語タイトル】Global Rhinitis Medicine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10170）・商品コード：LP23DC10170
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の鼻炎薬市場」は、過去の販売実績から2022年の世界の鼻炎薬の総販売量を検討し、2023年から2029年の予測される鼻炎薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の鼻炎薬の市場規模を掲載し、XXX百万米ドル規模の世界の鼻炎薬市場の詳細な分析を提供します。本インサイトレポートは、世界の鼻炎薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の鼻炎薬市場における各社の独自のポジションをより深く理解するために、鼻炎薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の鼻炎薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。鼻炎薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。鼻炎薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。鼻炎薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

鼻炎薬の世界主要メーカーとしては、GlaxoSmithKline、 Regeneron Pharmaceuticals、 Neurent Medical、 Lotus、 Glenmark、 Taiho Pharmaceutical、 Hikma Pharmaceuticals、 Med Globe Therapeutics Limited、 Stallergenes Greer、 AstraZeneca、 Bayer Globalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の鼻炎薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では鼻炎薬市場をセグメンテーションし、種類別 (抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬)、用途別 (アレルギー性鼻炎、感染性鼻炎、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬

・用途別区分：アレルギー性鼻炎、感染性鼻炎、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の鼻炎薬市場の10年間の市場状況・展望は？
・世界および地域別に見た鼻炎薬市場成長の要因は何か？
・鼻炎薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・鼻炎薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：鼻炎薬の年間販売量2018-2029、地域別現状・将来分析
・鼻炎薬の種類別セグメント：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬
・鼻炎薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・鼻炎薬の用途別セグメント：アレルギー性鼻炎、感染性鼻炎、その他
・鼻炎薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の鼻炎薬市場
・企業別のグローバル鼻炎薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の鼻炎薬の年間売上：2018-2023年の売上、市場シェア
・企業別の鼻炎薬販売価格
・主要企業の鼻炎薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

鼻炎薬の地域別レビュー
・地域別の鼻炎薬市場規模2018-2023：年間販売量、売上
・主要国別の鼻炎薬市場規模2018-2023：年間販売量、売上
・南北アメリカの鼻炎薬販売の成長
・アジア太平洋の鼻炎薬販売の成長
・ヨーロッパの鼻炎薬販売の成長
・中東・アフリカの鼻炎薬販売の成長

南北アメリカ市場
・南北アメリカの国別の鼻炎薬販売量、売上（2018-2023）
・南北アメリカの鼻炎薬の種類別販売量
・南北アメリカの鼻炎薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の鼻炎薬販売量、売上（2018-2023）
・アジア太平洋の鼻炎薬の種類別販売量
・アジア太平洋の鼻炎薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の鼻炎薬販売量、売上（2018-2023）
・ヨーロッパの鼻炎薬の種類別販売量
・ヨーロッパの鼻炎薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の鼻炎薬販売量、売上（2018-2023）
・中東・アフリカの鼻炎薬の種類別販売量
・中東・アフリカの鼻炎薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・鼻炎薬の製造コスト構造分析
・鼻炎薬の製造プロセス分析
・鼻炎薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・鼻炎薬の主要なグローバル販売業者
・鼻炎薬の主要なグローバル顧客

地域別の鼻炎薬市場予測レビュー
・地域別の鼻炎薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・鼻炎薬の種類別市場規模予測
・鼻炎薬の用途別市場規模予測

主要企業分析
GlaxoSmithKline、 Regeneron Pharmaceuticals、 Neurent Medical、 Lotus、 Glenmark、 Taiho Pharmaceutical、 Hikma Pharmaceuticals、 Med Globe Therapeutics Limited、 Stallergenes Greer、 AstraZeneca、 Bayer Global
・企業情報
・鼻炎薬製品
・鼻炎薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rhinitis Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rhinitis Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rhinitis Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rhinitis Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rhinitis Medicine players cover GlaxoSmithKline, Regeneron Pharmaceuticals, Neurent Medical, Lotus, Glenmark, Taiho Pharmaceutical, Hikma Pharmaceuticals, Med Globe Therapeutics Limited and Stallergenes Greer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Rhinitis Medicine Industry Forecast” looks at past sales and reviews total world Rhinitis Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Rhinitis Medicine sales for 2023 through 2029. With Rhinitis Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rhinitis Medicine industry.
This Insight Report provides a comprehensive analysis of the global Rhinitis Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rhinitis Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rhinitis Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rhinitis Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rhinitis Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Rhinitis Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Antihistamines
Nasal Spray Steroids
Antileukotrienes
Segmentation by application
Allergic Rhinitis
Infectious Rhinitis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
GlaxoSmithKline
Regeneron Pharmaceuticals
Neurent Medical
Lotus
Glenmark
Taiho Pharmaceutical
Hikma Pharmaceuticals
Med Globe Therapeutics Limited
Stallergenes Greer
AstraZeneca
Bayer Global
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rhinitis Medicine market?
What factors are driving Rhinitis Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rhinitis Medicine market opportunities vary by end market size?
How does Rhinitis Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rhinitis Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rhinitis Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rhinitis Medicine by Country/Region, 2018, 2022 & 2029
2.2 Rhinitis Medicine Segment by Type
2.2.1 Antihistamines
2.2.2 Nasal Spray Steroids
2.2.3 Antileukotrienes
2.3 Rhinitis Medicine Sales by Type
2.3.1 Global Rhinitis Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Rhinitis Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rhinitis Medicine Sale Price by Type (2018-2023)
2.4 Rhinitis Medicine Segment by Application
2.4.1 Allergic Rhinitis
2.4.2 Infectious Rhinitis
2.4.3 Others
2.5 Rhinitis Medicine Sales by Application
2.5.1 Global Rhinitis Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Rhinitis Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rhinitis Medicine Sale Price by Application (2018-2023)
3 Global Rhinitis Medicine by Company
3.1 Global Rhinitis Medicine Breakdown Data by Company
3.1.1 Global Rhinitis Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Rhinitis Medicine Sales Market Share by Company (2018-2023)
3.2 Global Rhinitis Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Rhinitis Medicine Revenue by Company (2018-2023)
3.2.2 Global Rhinitis Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Rhinitis Medicine Sale Price by Company
3.4 Key Manufacturers Rhinitis Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rhinitis Medicine Product Location Distribution
3.4.2 Players Rhinitis Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rhinitis Medicine by Geographic Region
4.1 World Historic Rhinitis Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Rhinitis Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rhinitis Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rhinitis Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Rhinitis Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rhinitis Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rhinitis Medicine Sales Growth
4.4 APAC Rhinitis Medicine Sales Growth
4.5 Europe Rhinitis Medicine Sales Growth
4.6 Middle East & Africa Rhinitis Medicine Sales Growth
5 Americas
5.1 Americas Rhinitis Medicine Sales by Country
5.1.1 Americas Rhinitis Medicine Sales by Country (2018-2023)
5.1.2 Americas Rhinitis Medicine Revenue by Country (2018-2023)
5.2 Americas Rhinitis Medicine Sales by Type
5.3 Americas Rhinitis Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rhinitis Medicine Sales by Region
6.1.1 APAC Rhinitis Medicine Sales by Region (2018-2023)
6.1.2 APAC Rhinitis Medicine Revenue by Region (2018-2023)
6.2 APAC Rhinitis Medicine Sales by Type
6.3 APAC Rhinitis Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rhinitis Medicine by Country
7.1.1 Europe Rhinitis Medicine Sales by Country (2018-2023)
7.1.2 Europe Rhinitis Medicine Revenue by Country (2018-2023)
7.2 Europe Rhinitis Medicine Sales by Type
7.3 Europe Rhinitis Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rhinitis Medicine by Country
8.1.1 Middle East & Africa Rhinitis Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rhinitis Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Rhinitis Medicine Sales by Type
8.3 Middle East & Africa Rhinitis Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rhinitis Medicine
10.3 Manufacturing Process Analysis of Rhinitis Medicine
10.4 Industry Chain Structure of Rhinitis Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rhinitis Medicine Distributors
11.3 Rhinitis Medicine Customer
12 World Forecast Review for Rhinitis Medicine by Geographic Region
12.1 Global Rhinitis Medicine Market Size Forecast by Region
12.1.1 Global Rhinitis Medicine Forecast by Region (2024-2029)
12.1.2 Global Rhinitis Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rhinitis Medicine Forecast by Type
12.7 Global Rhinitis Medicine Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Rhinitis Medicine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Regeneron Pharmaceuticals
13.2.1 Regeneron Pharmaceuticals Company Information
13.2.2 Regeneron Pharmaceuticals Rhinitis Medicine Product Portfolios and Specifications
13.2.3 Regeneron Pharmaceuticals Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Regeneron Pharmaceuticals Main Business Overview
13.2.5 Regeneron Pharmaceuticals Latest Developments
13.3 Neurent Medical
13.3.1 Neurent Medical Company Information
13.3.2 Neurent Medical Rhinitis Medicine Product Portfolios and Specifications
13.3.3 Neurent Medical Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Neurent Medical Main Business Overview
13.3.5 Neurent Medical Latest Developments
13.4 Lotus
13.4.1 Lotus Company Information
13.4.2 Lotus Rhinitis Medicine Product Portfolios and Specifications
13.4.3 Lotus Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lotus Main Business Overview
13.4.5 Lotus Latest Developments
13.5 Glenmark
13.5.1 Glenmark Company Information
13.5.2 Glenmark Rhinitis Medicine Product Portfolios and Specifications
13.5.3 Glenmark Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Glenmark Main Business Overview
13.5.5 Glenmark Latest Developments
13.6 Taiho Pharmaceutical
13.6.1 Taiho Pharmaceutical Company Information
13.6.2 Taiho Pharmaceutical Rhinitis Medicine Product Portfolios and Specifications
13.6.3 Taiho Pharmaceutical Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Taiho Pharmaceutical Main Business Overview
13.6.5 Taiho Pharmaceutical Latest Developments
13.7 Hikma Pharmaceuticals
13.7.1 Hikma Pharmaceuticals Company Information
13.7.2 Hikma Pharmaceuticals Rhinitis Medicine Product Portfolios and Specifications
13.7.3 Hikma Pharmaceuticals Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hikma Pharmaceuticals Main Business Overview
13.7.5 Hikma Pharmaceuticals Latest Developments
13.8 Med Globe Therapeutics Limited
13.8.1 Med Globe Therapeutics Limited Company Information
13.8.2 Med Globe Therapeutics Limited Rhinitis Medicine Product Portfolios and Specifications
13.8.3 Med Globe Therapeutics Limited Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Med Globe Therapeutics Limited Main Business Overview
13.8.5 Med Globe Therapeutics Limited Latest Developments
13.9 Stallergenes Greer
13.9.1 Stallergenes Greer Company Information
13.9.2 Stallergenes Greer Rhinitis Medicine Product Portfolios and Specifications
13.9.3 Stallergenes Greer Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Stallergenes Greer Main Business Overview
13.9.5 Stallergenes Greer Latest Developments
13.10 AstraZeneca
13.10.1 AstraZeneca Company Information
13.10.2 AstraZeneca Rhinitis Medicine Product Portfolios and Specifications
13.10.3 AstraZeneca Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AstraZeneca Main Business Overview
13.10.5 AstraZeneca Latest Developments
13.11 Bayer Global
13.11.1 Bayer Global Company Information
13.11.2 Bayer Global Rhinitis Medicine Product Portfolios and Specifications
13.11.3 Bayer Global Rhinitis Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Bayer Global Main Business Overview
13.11.5 Bayer Global Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rhinitis Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rhinitis Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Antihistamines
Table 4. Major Players of Nasal Spray Steroids
Table 5. Major Players of Antileukotrienes
Table 6. Global Rhinitis Medicine Sales by Type (2018-2023) & (K Units)
Table 7. Global Rhinitis Medicine Sales Market Share by Type (2018-2023)
Table 8. Global Rhinitis Medicine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Rhinitis Medicine Revenue Market Share by Type (2018-2023)
Table 10. Global Rhinitis Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Rhinitis Medicine Sales by Application (2018-2023) & (K Units)
Table 12. Global Rhinitis Medicine Sales Market Share by Application (2018-2023)
Table 13. Global Rhinitis Medicine Revenue by Application (2018-2023)
Table 14. Global Rhinitis Medicine Revenue Market Share by Application (2018-2023)
Table 15. Global Rhinitis Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Rhinitis Medicine Sales by Company (2018-2023) & (K Units)
Table 17. Global Rhinitis Medicine Sales Market Share by Company (2018-2023)
Table 18. Global Rhinitis Medicine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Rhinitis Medicine Revenue Market Share by Company (2018-2023)
Table 20. Global Rhinitis Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Rhinitis Medicine Producing Area Distribution and Sales Area
Table 22. Players Rhinitis Medicine Products Offered
Table 23. Rhinitis Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Rhinitis Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Rhinitis Medicine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Rhinitis Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Rhinitis Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Rhinitis Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Rhinitis Medicine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Rhinitis Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Rhinitis Medicine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Rhinitis Medicine Sales by Country (2018-2023) & (K Units)
Table 35. Americas Rhinitis Medicine Sales Market Share by Country (2018-2023)
Table 36. Americas Rhinitis Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Rhinitis Medicine Revenue Market Share by Country (2018-2023)
Table 38. Americas Rhinitis Medicine Sales by Type (2018-2023) & (K Units)
Table 39. Americas Rhinitis Medicine Sales by Application (2018-2023) & (K Units)
Table 40. APAC Rhinitis Medicine Sales by Region (2018-2023) & (K Units)
Table 41. APAC Rhinitis Medicine Sales Market Share by Region (2018-2023)
Table 42. APAC Rhinitis Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Rhinitis Medicine Revenue Market Share by Region (2018-2023)
Table 44. APAC Rhinitis Medicine Sales by Type (2018-2023) & (K Units)
Table 45. APAC Rhinitis Medicine Sales by Application (2018-2023) & (K Units)
Table 46. Europe Rhinitis Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Europe Rhinitis Medicine Sales Market Share by Country (2018-2023)
Table 48. Europe Rhinitis Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Rhinitis Medicine Revenue Market Share by Country (2018-2023)
Table 50. Europe Rhinitis Medicine Sales by Type (2018-2023) & (K Units)
Table 51. Europe Rhinitis Medicine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Rhinitis Medicine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Rhinitis Medicine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Rhinitis Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Rhinitis Medicine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Rhinitis Medicine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Rhinitis Medicine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Rhinitis Medicine
Table 59. Key Market Challenges & Risks of Rhinitis Medicine
Table 60. Key Industry Trends of Rhinitis Medicine
Table 61. Rhinitis Medicine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Rhinitis Medicine Distributors List
Table 64. Rhinitis Medicine Customer List
Table 65. Global Rhinitis Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Rhinitis Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Rhinitis Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Rhinitis Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Rhinitis Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Rhinitis Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Rhinitis Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Rhinitis Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Rhinitis Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Rhinitis Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Rhinitis Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Rhinitis Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Rhinitis Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Rhinitis Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. GlaxoSmithKline Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline Rhinitis Medicine Product Portfolios and Specifications
Table 81. GlaxoSmithKline Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Latest Developments
Table 84. Regeneron Pharmaceuticals Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 85. Regeneron Pharmaceuticals Rhinitis Medicine Product Portfolios and Specifications
Table 86. Regeneron Pharmaceuticals Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Regeneron Pharmaceuticals Main Business
Table 88. Regeneron Pharmaceuticals Latest Developments
Table 89. Neurent Medical Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 90. Neurent Medical Rhinitis Medicine Product Portfolios and Specifications
Table 91. Neurent Medical Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Neurent Medical Main Business
Table 93. Neurent Medical Latest Developments
Table 94. Lotus Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 95. Lotus Rhinitis Medicine Product Portfolios and Specifications
Table 96. Lotus Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Lotus Main Business
Table 98. Lotus Latest Developments
Table 99. Glenmark Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 100. Glenmark Rhinitis Medicine Product Portfolios and Specifications
Table 101. Glenmark Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Glenmark Main Business
Table 103. Glenmark Latest Developments
Table 104. Taiho Pharmaceutical Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 105. Taiho Pharmaceutical Rhinitis Medicine Product Portfolios and Specifications
Table 106. Taiho Pharmaceutical Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Taiho Pharmaceutical Main Business
Table 108. Taiho Pharmaceutical Latest Developments
Table 109. Hikma Pharmaceuticals Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 110. Hikma Pharmaceuticals Rhinitis Medicine Product Portfolios and Specifications
Table 111. Hikma Pharmaceuticals Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Hikma Pharmaceuticals Main Business
Table 113. Hikma Pharmaceuticals Latest Developments
Table 114. Med Globe Therapeutics Limited Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 115. Med Globe Therapeutics Limited Rhinitis Medicine Product Portfolios and Specifications
Table 116. Med Globe Therapeutics Limited Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Med Globe Therapeutics Limited Main Business
Table 118. Med Globe Therapeutics Limited Latest Developments
Table 119. Stallergenes Greer Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 120. Stallergenes Greer Rhinitis Medicine Product Portfolios and Specifications
Table 121. Stallergenes Greer Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Stallergenes Greer Main Business
Table 123. Stallergenes Greer Latest Developments
Table 124. AstraZeneca Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 125. AstraZeneca Rhinitis Medicine Product Portfolios and Specifications
Table 126. AstraZeneca Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. AstraZeneca Main Business
Table 128. AstraZeneca Latest Developments
Table 129. Bayer Global Basic Information, Rhinitis Medicine Manufacturing Base, Sales Area and Its Competitors
Table 130. Bayer Global Rhinitis Medicine Product Portfolios and Specifications
Table 131. Bayer Global Rhinitis Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Bayer Global Main Business
Table 133. Bayer Global Latest Developments
List of Figures
Figure 1. Picture of Rhinitis Medicine
Figure 2. Rhinitis Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rhinitis Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rhinitis Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rhinitis Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Antihistamines
Figure 10. Product Picture of Nasal Spray Steroids
Figure 11. Product Picture of Antileukotrienes
Figure 12. Global Rhinitis Medicine Sales Market Share by Type in 2022
Figure 13. Global Rhinitis Medicine Revenue Market Share by Type (2018-2023)
Figure 14. Rhinitis Medicine Consumed in Allergic Rhinitis
Figure 15. Global Rhinitis Medicine Market: Allergic Rhinitis (2018-2023) & (K Units)
Figure 16. Rhinitis Medicine Consumed in Infectious Rhinitis
Figure 17. Global Rhinitis Medicine Market: Infectious Rhinitis (2018-2023) & (K Units)
Figure 18. Rhinitis Medicine Consumed in Others
Figure 19. Global Rhinitis Medicine Market: Others (2018-2023) & (K Units)
Figure 20. Global Rhinitis Medicine Sales Market Share by Application (2022)
Figure 21. Global Rhinitis Medicine Revenue Market Share by Application in 2022
Figure 22. Rhinitis Medicine Sales Market by Company in 2022 (K Units)
Figure 23. Global Rhinitis Medicine Sales Market Share by Company in 2022
Figure 24. Rhinitis Medicine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Rhinitis Medicine Revenue Market Share by Company in 2022
Figure 26. Global Rhinitis Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Rhinitis Medicine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Rhinitis Medicine Sales 2018-2023 (K Units)
Figure 29. Americas Rhinitis Medicine Revenue 2018-2023 ($ Millions)
Figure 30. APAC Rhinitis Medicine Sales 2018-2023 (K Units)
Figure 31. APAC Rhinitis Medicine Revenue 2018-2023 ($ Millions)
Figure 32. Europe Rhinitis Medicine Sales 2018-2023 (K Units)
Figure 33. Europe Rhinitis Medicine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Rhinitis Medicine Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Rhinitis Medicine Revenue 2018-2023 ($ Millions)
Figure 36. Americas Rhinitis Medicine Sales Market Share by Country in 2022
Figure 37. Americas Rhinitis Medicine Revenue Market Share by Country in 2022
Figure 38. Americas Rhinitis Medicine Sales Market Share by Type (2018-2023)
Figure 39. Americas Rhinitis Medicine Sales Market Share by Application (2018-2023)
Figure 40. United States Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Rhinitis Medicine Sales Market Share by Region in 2022
Figure 45. APAC Rhinitis Medicine Revenue Market Share by Regions in 2022
Figure 46. APAC Rhinitis Medicine Sales Market Share by Type (2018-2023)
Figure 47. APAC Rhinitis Medicine Sales Market Share by Application (2018-2023)
Figure 48. China Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Rhinitis Medicine Sales Market Share by Country in 2022
Figure 56. Europe Rhinitis Medicine Revenue Market Share by Country in 2022
Figure 57. Europe Rhinitis Medicine Sales Market Share by Type (2018-2023)
Figure 58. Europe Rhinitis Medicine Sales Market Share by Application (2018-2023)
Figure 59. Germany Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Rhinitis Medicine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Rhinitis Medicine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Rhinitis Medicine Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Rhinitis Medicine Sales Market Share by Application (2018-2023)
Figure 68. Egypt Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Rhinitis Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Rhinitis Medicine in 2022
Figure 74. Manufacturing Process Analysis of Rhinitis Medicine
Figure 75. Industry Chain Structure of Rhinitis Medicine
Figure 76. Channels of Distribution
Figure 77. Global Rhinitis Medicine Sales Market Forecast by Region (2024-2029)
Figure 78. Global Rhinitis Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Rhinitis Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Rhinitis Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Rhinitis Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Rhinitis Medicine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の鼻炎薬市場予測 2023年-2029年] (コード：LP23DC10170)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の鼻炎薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医療用内服薬市場予測 2023年-2029年
  • 世界の腹圧性尿失禁用治療薬市場予測 2023年-2029年
  • 世界の薬用乾燥剤市場予測 2023年-2029年
  • 世界のメマンチン塩酸塩API市場予測 2023年-2029年
  • 世界のスコポラミン臭化ブチルカプセル市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆